PTC Therapeutics (PTCT)
(Real Time Quote from BATS)
$38.07 USD
+0.16 (0.42%)
Updated Jun 5, 2024 02:53 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Brokerage Reports
0 items in cart
PTC Therapeutics, Inc. [PTCT]
Reports for Purchase
Showing records 21 - 40 ( 147 total )
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Downgrading to NEUTRAL with $11 PT; Lower Translarna Estimates Shift Risk/Reward
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Unfortunate Timing of German Assessment; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Increased Regulatory Uncertainty After Translarna Stumbles in the US; Reiterate OUTPERFORM but Lower our PT to $27 from $65
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Increased Regulatory Uncertainty After Translarna Stumbles in the US; Reiterate OUTPERFORM but Lower our PT to $27 from $65
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Feb. 1This report contains brief updates on the following: SRPT, RGLS, BMRN, CBYL, CLDX, EPRS, LXRX, PCRX, PRTA, PTCT, RPTP, TTPH, RARE, VTAE, ICPT, CERU, FCSC, GBT, TSRO, TRVN, IRWD, MRTX, DNAI, XNCR. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Tweaking our Estimates Based on Rapid Translarna Launch; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
PTC Brings New Molecule Forward for SMA Program with Roche; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Transferring Covaerage
Provider: Roth Capital Partners, Inc.
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
PTC Reports Strong 3Q15 Translarna Sales as it Prepares to Complete NDA Submission; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Strong Patient Build, Awaiting Clarity on ACT-DMD Baseline
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
3Q Preview - Focus on Regulatory Strategy and Ongoing ROW Launch
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 2This report contains brief updates on the following: DYAX, ANAC, IRWD, ECYT, FATE, XNCR, RGLS, MGNX, FCSC, SNSS, INFI, MDVN, RPTP, SRPT, XOMA, AGTC, EPZM, BLUE, PTCT, CATB, EPRS, ABUS, ICPT. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals: Potential Ripple Effect of Drisapersen''s Advisory Panel
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Translarna Misses Primary but Likely a Path Forward; Reiterate OUTPERFORM and Decreasing PT to $65
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Upcoming Test for the "Flexible Global Regulatory Environment Thesis"
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Full SMA Data Presented at WMS; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H